drugset

drugset / Trial / NCT00538148

Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD

NCT00538148 ↗

Phase 4 Completed 668 enrolled Sanofi

RandomizedParallel-groupDouble-blindTreatment

Summary

Non-inferiority efficacy of telithromycin versus azithromycin

Timeline

Start: 2002-11
Primary completion: 2004-09
Completion: 2004-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Telithromycin	Small molecule	800 mg	Oral

Indications